RBP4 and metabolic syndrome: RBP4 contributes to HUA–induced IR, at least partially by inhibiting the phosphorylation of the IRS/PI3K/Akt signaling pathway in adipocytes, and thereby affecting glucose uptake and inducing metabolic syndrome.